title: Trials and tribulations of noninferiority: caveat emptor.
authors.affiliation: Office of the Chief Medical Officer, Merck, Upper Gwynedd, Pennsylvania.
authors.forename: Mark J
authors.initials: MJ
authors.lastname: DiNubile
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D016470:Bacteremia / Q000188:drug therapy* / Q000382:microbiology*; D002437:Cefazolin / Q000627:therapeutic use*; D005260:Female; D006020:Glycopeptides / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D016106:Methicillin Resistance; D017192:Skin Diseases, Bacterial / Q000188:drug therapy*; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology*; D014640:Vancomycin / Q000008:administration & dosage* / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D006020:Glycopeptides; D014640:Vancomycin; D002437:Cefazolin